← Back to Search

Wearable Technology for Post COVID-19 Syndrome

N/A
Recruiting
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Mild to severe persistent respiratory symptoms
Be older than 18 years old
Must not have
Inability to ambulate independently without supervision
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 week
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if using wearable technology can help people with post-COVID-19 syndrome manage their symptoms better. The study will also look at how feasible and effective this approach is, which

Who is the study for?
This trial is for individuals who have had COVID-19 and are experiencing persistent respiratory symptoms for at least 3 months after infection. Participants must have access to home internet to use the wearable biometric technology.
What is being tested?
The study tests a self-management program using wearable biometric devices to monitor health data in people with long-term respiratory issues after COVID-19. It aims to assess how this approach affects their recovery.
What are the potential side effects?
Since the intervention involves self-management and monitoring through wearable technology, there are no direct medical side effects associated with drugs or invasive procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I experience ongoing mild to severe breathing problems.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I need help to walk and cannot do it alone.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 week for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Dyspnea
Change in fatigue
Change in lung capacity
+4 more
Secondary study objectives
Patient satisfaction with the study
Symptoms change

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: One armExperimental Treatment1 Intervention
Self-management group. This pilot-study uses a one-group before-after design.

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
621 Previous Clinical Trials
206,543 Total Patients Enrolled
~10 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top